SEOUL, Korea--(BUSINESS WIRE)--Nov 9, 2023--GenScript ProBio, a global multimodality CDMO and NuclixBio, a company developing treatments based on circular RNA, announced on 9th Nov that they have entered into a strategic business agreement to develop the first circular RNA-based anticancer drug ...
A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.The U.S. Food and Drug Administration approved Eli Lilly's drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in ...
GOLETA, Calif.--(BUSINESS WIRE)--Nov 8, 2023--Serimmune:<em>WHAT:</em> Serimmune will discuss its Serum Epitope Repertoire Analysis (SERA) platform and how it can be applied in various studies to gain insight into past and present humoral immune responses in ...
STOCKHOLM--(BUSINESS WIRE)--Nov 8, 2023--Xspray Pharma AB (Stockholm/Nasdaq: XSPRAY) a biotechnology company developing improved TKIs for cancer treatment, through its proprietary HyNap™ technology, today announced the results from drug interaction studies demonstrating that DASYNOC’s ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Nov 8, 2023--<a ...
--(BUSINESS WIRE)--Nov 8, 2023--<em>WHAT:</em> Serimmune will discuss its Serum Epitope Repertoire Analysis (SERA) platform and how it can be applied in various studies to gain insight into past and present humoral immune responses in individuals and cohorts. The new ...
